Academic Journal

Glycopyrronium bromide is a new long-acting anticholinergic drug for the treatment of COPD

Bibliographic Details
Title: Glycopyrronium bromide is a new long-acting anticholinergic drug for the treatment of COPD
Authors: S. N. Avdeev, S. Y. Chikina
Source: Медицинский совет, Vol 0, Iss 16, Pp 6-11 (2014)
Publisher Information: Remedium Group LLC, 2014.
Publication Year: 2014
Collection: LCC:Medicine
Subject Terms: гликопирроний, м-холинорецепторы, хроническая обструктивная болезнь легких, бронходилата-ция, обострения, качество жизни, безопасность, glycopyrronium, m-cholinergic receptors, chronic obstructive pulmonary disease, bronchodilation, exacerbations, quality of life, safety, Medicine
Description: Glycopyrronium is a new powerful quick-acting anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease. Glycopyrronium is powder in Breezhaler® inhalation device. The review tells about phase III clinical trials demonstrating the positive effect of glycopyrronium on lung function, symptoms of the disease, exercise tolerance, frequency of severe and moderate COPD exacerbations and quality of life of patients. The drug showed good tolerability and high cardiac safety in a long-term period.
Document Type: article
File Description: electronic resource
Language: Russian
ISSN: 2079-701X
2658-5790
Relation: https://www.med-sovet.pro/jour/article/view/754; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790
DOI: 10.21518/2079-701X-2014-16-6-11
Access URL: https://doaj.org/article/9c05b67237d143108ad94e8fa039e66f
Accession Number: edsdoj.9c05b67237d143108ad94e8fa039e66f
Database: Directory of Open Access Journals
Be the first to leave a comment!
You must be logged in first